BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28892121)

  • 1. Statins for Primary Prevention of Cardiovascular Events and Mortality in Older Men.
    Orkaby AR; Gaziano JM; Djousse L; Driver JA
    J Am Geriatr Soc; 2017 Nov; 65(11):2362-2368. PubMed ID: 28892121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
    Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
    JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
    JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes.
    Andersson T; Nåtman J; Mourtzinis G; Bager JE; Bengtsson Boström K; Franzén S; Hjerpe P
    Eur J Prev Cardiol; 2023 Nov; 30(17):1883-1894. PubMed ID: 37368941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
    Shavadia JS; Wilson J; Edmonston D; Platt A; Ephraim P; Hall R; Goldstein BA; Boulware LE; Peterson E; Pendergast J; Scialla JJ
    Am Heart J; 2021 Jan; 231():36-44. PubMed ID: 33096103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Statins as Primary Prevention in People With Gout: A Population-Based Cohort Study.
    Garcia-Gil M; Comas-Cufí M; Ramos R; Martí R; Alves-Cabratosa L; Parramon D; Prieto-Alhambra D; Baena-Díez JM; Salvador-González B; Elosua R; Dégano IR; Marrugat J; Grau M
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):542-550. PubMed ID: 31248268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts.
    Blackburn R; Osborn D; Walters K; Falcaro M; Nazareth I; Petersen I
    BMJ Open; 2017 Mar; 7(3):e013154. PubMed ID: 28270387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis.
    Degli Esposti L; Saragoni S; Batacchi P; Benemei S; Geppetti P; Sturani A; Buda S; Degli Esposti E
    Clin Ther; 2012 Jan; 34(1):190-9. PubMed ID: 22284998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use reduces cardiovascular events and all-cause mortality amongst Chinese patients with type 2 diabetes mellitus: a 5-year cohort study.
    Fung CSC; Wan EYF; Chan AKC; Lam CLK
    BMC Cardiovasc Disord; 2017 Jun; 17(1):166. PubMed ID: 28645252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study.
    Lemaitre RN; Psaty BM; Heckbert SR; Kronmal RA; Newman AB; Burke GL
    Arch Intern Med; 2002 Jun; 162(12):1395-400. PubMed ID: 12076239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
    Lee CJ; Oh J; Lee SH; Kang SM; Choi D; Kim HC; Park S
    J Hypertens; 2017 May; 35 Suppl 1():S33-S40. PubMed ID: 28129248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
    Sesso HD; Christen WG; Bubes V; Smith JP; MacFadyen J; Schvartz M; Manson JE; Glynn RJ; Buring JE; Gaziano JM
    JAMA; 2012 Nov; 308(17):1751-60. PubMed ID: 23117775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.
    Foody JM; Rathore SS; Galusha D; Masoudi FA; Havranek EP; Radford MJ; Krumholz HM
    J Am Geriatr Soc; 2006 Mar; 54(3):421-30. PubMed ID: 16551308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.